This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 159 
2 out of 100 Years Active: 2022-2024
Title: Fei Teng: Innovator in Antibody Development
Introduction
Fei Teng is a prominent inventor based in Suzhou, China, known for his significant contributions to the field of biotechnology. With a focus on antibody development, he has made strides in creating innovative solutions for medical applications. His work has led to the filing of two patents that showcase his expertise and dedication to advancing healthcare.
Latest Patents
Fei Teng's latest patents include a human IL-4R binding antibody and an anti-CD40 antibody. The first patent relates to a human IL-4R binding antibody, an antigen binding fragment thereof, and its medical use. This invention provides a chimeric antibody and a humanized antibody that includes a CDR region from a human IL-4R binding antibody. It also details a pharmaceutical composition that includes the human IL-4R binding antibody and its use as a drug for treating allergic diseases. The second patent focuses on an anti-CD40 antibody, its antigen binding fragment, and its medical applications. This invention also includes a chimeric antibody and a humanized antibody, along with a pharmaceutical composition for treating CD40-mediated diseases or disorders.
Career Highlights
Fei Teng has worked with notable companies in the pharmaceutical industry, including Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to collaborate with leading professionals in the field and contribute to groundbreaking research.
Collaborations
Fei Teng has collaborated with esteemed colleagues such as Jiahua Jiang and Lianshan Zhang. These partnerships have further enhanced his research capabilities and have played a crucial role in the development of his innovative patents.
Conclusion
Fei Teng's work in antibody development exemplifies the impact of innovation in the medical field. His patents not only contribute to scientific knowledge but also hold the potential to improve treatment options for various diseases. His dedication to research and collaboration continues to drive advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile